Business Context and Reporting Period
Company: Alphatec Holdings, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: March 26, 2010
Event: Completion of the acquisition of Scient'x S.A., a global medical device company based in France specializing in surgical implants for spinal disorders. Scient'x is now a wholly owned indirect subsidiary of Alphatec.
Key Financial Metrics and Transaction Details
- Acquisition Consideration: The aggregate purchase price for 100% of Scient'x was 23,730,644 shares of Alphatec common stock. The original agreement fixed consideration at 24,000,000 shares, reduced by shares exchanged for fees and expenses incurred by HealthpointCapital.
- Ownership Structure Post-Transaction: HealthpointCapital Partners, L.P. and HealthpointCapital Partners II, L.P. (collectively "HealthpointCapital") own approximately 54.5% of Alphatec's common stock as of March 31, 2010.
- Financial Statements: Audited consolidated financial statements for Scient'x for fiscal years ended December 31, 2009 and 2008, and pro forma consolidated financial statements for Alphatec and Scient'x as of December 31, 2009, are filed as Exhibits 99.1 and 99.2, respectively.
- Revenue, Profit, and Cash Flow: The filing text does not provide specific revenue, profit, cash flow, margin, debt, or liquidity figures for Alphatec or Scient'x within the narrative; these are contained in the referenced exhibits.
Material Changes Versus Prior Period
- Asset Acquisition: Alphatec expanded its operations by acquiring 100% of Scient'x, moving from a disclosed definitive agreement (December 22, 2009) to completed ownership.
- Shareholder Composition: HealthpointCapital's ownership stake in Alphatec increased from approximately 39.5% to approximately 54.5% following the issuance of shares for the acquisition.
- Corporate Governance: Five Alphatec directors are beneficial owners of or affiliated with HealthpointCapital, and three of these directors also serve on the board of Scient'x or its affiliates.
Guidance, Outlook, and Material Agreements
- Registration Rights Agreement: A new agreement was entered into with former Scient'x shareholders (Registration Rights Holders).
- Demand Rights: HealthpointCapital may demand registration of shares after June 24, 2010, provided the market value is at least $10 million or represents 3% of total outstanding shares.
- Piggy-Back Rights: Holders are entitled to include shares in future registrations, subject to underwriter limitations.
- Lock-Up Provisions: Holders agreed not to sell or hedge shares during the 10 days prior to and 90 days after the effective time of an underwritten piggy-back registration.
- Unregistered Sales: The issuance of shares for the acquisition relied on the Section 4(2) exemption from registration under the Securities Act.
- Outlook: The filing does not contain specific forward-looking guidance or management commentary regarding future financial performance beyond the completion of the transaction.
Key Facts for Investor Verification
- Verify the pro forma financial impact of the acquisition by reviewing Exhibit 99.2 (Pro Forma Consolidated Financial Statements).
- Review the audited financial statements of Scient'x (Exhibit 99.1) to assess the target's historical financial health.
- Monitor the potential dilution and market impact of the Registration Rights Agreement, specifically the demand rights exercisable after June 24, 2010.
- Confirm the extent of related-party transactions given that HealthpointCapital now controls approximately 54.5% of the company and shares directors with the acquired entity.